CD36 and hematoma: Recent insights underscore the regulation of Mφ phagocytosis via the LRRC8A channel through the AMPK-Nrf2-CD36 pathway following ICH, suggesting LRRC8A as a potential therapeutic target for enhancing hematoma clearance (108).